GORDON CONFERENCE ON CANCER CHEMOTHERAPY

戈登癌症化疗会议

• 批准号: 2713002
• 负责人: NEIL W GIBSON
• 金额: $ 0.5万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-07-01 至 1999-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2713002
• 关键词: meeting /conference /symposium; neoplasm /cancer; neoplasm /cancer chemotherapy

DESCRIPTION (Applicant's Description): The Gordon Research Conference on Experimental and Clinical Cancer is an annual meeting that brings together basic research scientists, biotechnology, pharmaceutical and clinical personnel involved in the discovery and/or evaluation of anticancer agents or stratagems. This meeting aims to catalyze advancements in the treatment of human cancer. This is achieved through the presentation of novel and unpublished research findings in contemporary areas of cancer research from leading and emerging individuals. These presentations tend to focus discussion on the translation of such knowledge into practical aspects of better cancer-patient care. In the present application, funds are requested to partially support the 1998 Conference which will emphasize (1) the usefulness of new and emerging functional genomic technologies for identification of new anticancer targets and (2) the exploitation of emerging knowledge on tumor suppressor/oncogene pathways that impact upon cell cycle control and/or apoptosis as a route to more incisive cancer treatment approaches.

描述（申请人的描述）：戈登研究会议 实验性和临床癌是一场年度会议，汇集了 基础研究科学家，生物技术，药物和临床 涉及抗癌药发现和/或评估的人员 或策略。 这次会议旨在促进治疗方面的进步 人类癌症。 这是通过出现小说和 当代癌症研究中未发表的研究结果 领导和新兴个人。 这些演讲倾向于集中 讨论将这种知识转化为实际方面 更好的癌症患者护理。 在本申请中，请求资金 部分支持1998年会议，该会议将强调（1） 新的和新兴的功能基因组技术的有用性 确定新的抗癌目标，（2）开发 对影响肿瘤抑制剂/癌基途径的新兴知识 细胞周期控制和/或细胞凋亡作为一种更尖锐癌症的途径 治疗方法。